Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA	Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasm	Recruiting	Not stated	2025-02-26		NCT05461664

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Hospital of Guangxi Medical University	22
Chinese PLA General Hospital	238
Chongqing University Cancer Hospital	41
First Affiliated Hospital of Chongqing Medical University	101
Fudan University	653
Fujian Medical University Union Hospital	108
Jiangsu Cancer Institute & Hospital	45
Liaoning Cancer Hospital & Institute	53
Nanfang Hospital, Southern Medical University	248
Peking University Cancer Hospital & Institute	189
Peking University People's Hospital	269
Peking University Shenzhen Hospital	48
Shanghai Jiao Tong University School of Medicine	117
Shanghai Zhongshan Hospital	347
Shengjing Hospital	111
Sixth Affiliated Hospital, Sun Yat-sen University	122
Sun Yat-Sen University Cancer Center	74
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319
West China Hospital	359
Xiangya Hospital of Central South University	162
Xijing Hospital	177
Xinhua Zhang, MD	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital, Sun Yat-sen University	Guangzhou	China	12

Clinical trials